🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT05139160
Active, not recruiting Not applicable

Aminoacidemia and Protein Kinetics in Response to the Ingestion of Plant-based Protein Blends

NCT05139160 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2022-08-15
Last updated
2024-10-08

Condition(s) studied

Nutrition, Healthy

Investigational drug(s) / intervention(s)

Protein quality

Protein quality: the present investigation aims to study a novel protein based protein isolate blend with and without leucine an compared with whey protein isolate to determine its impact aminoacidemia and muscle protein synthesis healthy adults.

Study summary

The present investigation aims to study a novel plant based protein isolate blend to determine if it results in similar muscle building responses compared to whey protein isolate.

Eligibility

Sex
ALL
Min age
18 Years
Max age
30 Years
Healthy volunteers
Accepted
Inclusion Criteria: 1. Male or female, between the ages of 18 - 30 years (inclusive) 2. Have a body mass index (BMI) between 18-30 kg·m2 (inclusive) 3. Be in general good health as assessed by a general health questionnaire 4. Non-smoking 5. Regular menstrual cycle and not using hormonal contraceptives 6. Willing and able to provide informed consent Exclusion Criteria: 1. Currently using analgesic or anti-inflammatory drugs 2. A history of neuromuscular problems or muscle and/or bone wasting diseases 3. Any acute or chronic illness, metabolic disorders 4. Currently using corticosteroids 5. Use of hormonal contraceptives or anabolic steroids (e.g. testosterone)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Changhyun Lim Hamilton Ontario

More McMaster University trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05139160 on ClinicalTrials.gov ↗ ← All trials in Canada